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In many Asian population, metabolic 
disorders rise relatively easily even in non-
obese subjects (BMI<25 kg/m2). However the 
clear mechanism of metabolic disorders in non-
obese subjects has not been fully explained. 
In Indonesia, as many as 19.7% of men and 
32.9% of women are obese, and 26.6% of adult 
population have central obesity.1 Riskesdas’ 
study also demonstrated that Indonesian people 
tend to have high carbohydrate diet, high fat 
diet, and low fiber diet. Approximately 50% of 
Indonesian people take unhealthy food (sweet 
and fatty) and more than 90% take low fiber 
diet. Furthermore, around a quarter of Indonesian 
people have sedentary activity >6 hour per day 
and it worsen along with age (especially >50 
years old).1 Excessive energy intake and low 
physical activity will induce obesity and other 
metabolic derangement. Obesity stays as the 
main cause of insulin resistance, type 2 diabetes 
and cardiovascular disease. However, as many as 
30% of obese people do not have hypertension, 
dyslipidemia, or glucose intolerance. On the 
contrary, those metabolic disorders can happen 
among 20-30% of non-obese people. Both diet 
and physical activity have been considered to 
regulate intracellular lipid accumulation and 
associated with insulin sensitivity in muscle and 
liver independent of body weight.2
Ectopic fat accumulation due to adipose 
tissue dysfunction is not clearly understood. 
Several factors such as genetic, environmental 
and behavioral components are included in 
energy metabolism as well as physiologic 
versus pathologic fat accumulation.3 There are 
2 kinds of body fat distribution, visceral fat and 
subcutaneous fat distribution, which can be 
determined using CT-scan at umbilicus level. 
Visceral fat obesity has significant positive 
correlation with metabolic profile such as blood 
glucose, lipid profile and blood pressure. Beside 
fat’s volume, fat’s quality, determined by multiple 
detector computed tomography (MDCT), is 
associated with adverse cardiovascular risk.4
Physiologically, adipose tissue can store 
large amount of triglyceride. If the adipose 
tissue secretes adipokines with proinflammatory 
properties, it will stimulate ectopic fat 
accumulation in other tissues. Normally, 
tissues other than adipose tissue such as liver, 
skeletal muscle, heart, and pancreas, contain 
small amount of fat. Ectopic fat accumulation 
will disturb cellular function and thus disturb 
organ function, and is connected with insulin 
resistance.3,5
Insulin resistance is defined as an insufficient 
response to the biologic effects of insulin in 
tissues, such as skeletal muscle, liver, and 
adipose tissue. Clinically, there is difference 
between muscle insulin resistance and hepatic 
insulin resistance. Subjects with muscle insulin 
resistance will develop impaired fasting glucose 
while subjects with hepatic insulin resistance 
will demonstrate impaired fasting glucose. Fat 
accumulation in the liver lead to hepatic steatosis 
and insulin resistance.5,6
Ectopic fat accumulation in the liver 
without history of excessive alcohol intake is 
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indicated to as nonalcoholic fatty liver disease 
(NAFLD). Liver abnormalities in NAFLD 
ranges from hepatic steatosis with or without 
increases in serum transaminases to nonalcoholic 
steatohepatitis (NASH) with or without fibrosis, 
cirrhosis, and hepatocellular carcinoma. The 
prevalence of NAFLD is about 20% in general 
population, in varying degree across countries.3,7 
In Indonesia, there are only few studies about 
NAFLD. In 2015, Lesmana reported that the 
prevalence of NAFLD among healthy subject 
who underwent medical check up at private 
hospital was 51% (538 of 1054). There were 6 
factors which are related to NAFLD: male sex, 
age >35 years, obese, hypertriglyceridemia, 
low HDL cholesterol, and high serum alanine 
aminotransferase (ALT).8 In the previous study, 
Lesmana compared the clinical picture, insulin 
resistance status, and adipocytokines profiles 
of subject with NASH in Jakarta, Indonesia. 
They reported that subject with NASH had 
worse insulin resistance profile, which is 
known by greater HOMA-IR value, than that 
of subject without NASH. Besides, the level 
of proinfammatory cytokines such as tumor 
necrosis factor alpha (TNF-alpha) among subject 
with NASH was higher than that of control.7 
TNF alpha is known as potent proinflamamtory 
cytokines which play a role in the progression of 
atherosclerotic lesion. Further study is needed to 
investigate the progression of NAFLD and the 
following risk of cardiovascular endpoint among 
Indonesian people.
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